Scopolamine Hydrobromide

CAS 114-49-8 4 current records 1 historicalSmall Molecule

Who holds supplier records for Scopolamine Hydrobromide? 4 organisations hold a current record for Scopolamine Hydrobromide: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Australia (1), United States (1) and India (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Scopolamine Hydrobromide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/scopolamine-hydrobromide

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Scopolamine Hydrobromide. Country is the organisation's recorded country, not necessarily the manufacturing site.

Australia1United States1India1Country not recorded for 1
  • Phytex Australia Pty Ltd
    Active DMF 7415 · latest filing Mar 1988
    AustraliaCEP
  • ALCHEM INTERNATIONAL LTD
    Active DMF 30721 · latest filing Jul 2016
    United States
  • ALKALOIDS CORP
    Active DMF 31708 · latest filing May 2017
    India
  • ALKALOIDS PRIVATE LTD
    CEP
Need Scopolamine Hydrobromide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Scopolamine Hydrobromide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 4 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ALKALOIDS PRIVATE LIMITED SecunderabadIN
CEP 2019-152 - Rev 03
Hyoscine hydrobromide hydrate
Sept 2026—
PHYTEX AUSTRALIA PTY LTD. PeakhurstAU
R0-CEP 2020-377 - Rev 00
Hyoscine hydrobromide hydrate
May 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Scopolamine Hydrobromide are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Scopolamine hydrobromide is an anticholinergic agent used to prevent nausea and motion sickness. It also has applications in ophthalmic procedures to induce mydriasis and cycloplegia.

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Anticholinergic
Mechanism of action
Cholinergic Antagonists

Therapeutic areas

GastroenterologyNeurologyOphthalmology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Scopolamine Hydrobromide?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Scopolamine Hydrobromide: Phytex Australia Pty Ltd (Australia), ALCHEM INTERNATIONAL LTD (United States), ALKALOIDS CORP (India) and ALKALOIDS PRIVATE LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Scopolamine Hydrobromide Drug Master Files are active?

Phytex Australia Pty Ltd (DMF 7415), ALCHEM INTERNATIONAL LTD (DMF 30721) and ALKALOIDS CORP (DMF 31708). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Scopolamine Hydrobromide records mean?

1 organisation has only inactive Type II DMFs for Scopolamine Hydrobromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Scopolamine Hydrobromide have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Scopolamine Hydrobromide on the EDQM register, including ALKALOIDS PRIVATE LIMITED Secunderabad (IN) and PHYTEX AUSTRALIA PTY LTD. Peakhurst (AU). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Scopolamine Hydrobromide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Scopolamine Hydrobromide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.